{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-022465","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.134985+00:00","generated_at":"2026-06-25T04:54:11.214602+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TherapeuticsMD signs merger agreement with Athene Parent for cash tender offer and merger","bullets":["Merger Agreement dated May 27, 2022 with Athene Parent, Inc. and Athene Merger Sub, Inc.","Cash tender offer to acquire all outstanding TXMD common shares, followed by a merger.","Board amended bylaws to exempt the transaction from Nevada's control share acquisition statute.","No deal price, premium, or expected closing date disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-022465","json":"https://secwatch.observer/filing/0001564590-22-022465.json","markdown":"https://secwatch.observer/filing/0001564590-22-022465.md","text":"https://secwatch.observer/filing/0001564590-22-022465.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/0001564590-22-022465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000156459022022465/txmd-8k_20220527.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:54:11.214602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}